ENTITY
SMARTSCORE: 2.8/5
Genomma Lab Internacional Sab

Genomma Lab Internacional Sab (LABB MM)

12
Analysis
Health CareMexico
Genomma Lab Internacional SAB de CV develops, markets, sells and distributes over-the-counter drugs and personal care products.
more
18 Mar 2025 14:00Syndicated

Actinver Research - Genomma Lab 4Q24: Strong finish and positive outlook

Revenues of P$4.7bn grew 32.4% YoY, supported by healthy growth across all regions and FX tailwinds (e.g., U.S. sales grew 1.8% in local currency,...

Logo
Actinver
217 Views
Share
27 Feb 2025 04:00Syndicated

Actinver Research - Genomma Lab 4Q24: Healthy finish of the year (Quick View)

Revenues of P$4.7bn grew 32.4% YoY, supported by healthy growth across all regions. Sales in Mexico were in line with our estimates, while in...

Logo
Actinver
252 Views
Share
10 Dec 2024 15:00Syndicated

Actinver Research - Genomma Lab: Reaching Healthier Valuation Levels (Company Update)

After a stunning YTD performance (up 90.68% as of 12/9/24 vs MEXBOL 9.05% down), we continue to see solid upside ahead. Market conditions for most...

Logo
Actinver
283 Views
Share
24 Oct 2024 15:00Syndicated

Actinver Research - Genomma Lab 3Q24: Strong across the board (Quick View)

Revenues of P$5.1bn grew 15.9% YoY and were 6.8% above our estimates, supported by healthy growth across all regions. For a second consecutive...

Logo
Actinver
202 Views
Share
bullishMacroeconomics
12 May 2025 17:02Syndicated

Actinver Research - Consumer Post 1Q25 Update

Soft consumer environment, with weaker conditions at the beginning of the year vs the company’s expectations; a warmer season didn’t help either.

Logo
Actinver
188 Views
Share
x